Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine intercostal nerve block after thoracoscopic lung cancer resection across age groups
ChiCTR2500103721Phase 4Not yet recruiting
- Sponsor
- Yibin Second People's Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bupivacaine in postoperative pain and bronchial carcinoma (3 arms), sponsored by Yibin Second People's Hospital. Primary endpoint: Pain scores at 96 hours. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative painbronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2500103721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103721.